cabergoline has been researched along with Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casulari, LA; de Castro, LF; de Fátima Magalhães Gonzaga, M; Kessler, IM; Mendonça, JL | 1 |
| Arai, T; Fujiwara, H; Sekizawa, K; Toshima, S; Yoshimi, N | 1 |
| Gomes, MC; Knoepfelmacher, M; Melo, ME; Mendonca, BB | 1 |
1 trial(s) available for cabergoline and Stroke
| Article | Year |
|---|---|
Cabergoline and silent aspiration in elderly patients with stroke.
Topics: Aged; Cabergoline; Deglutition Disorders; Dopamine Agonists; Ergolines; Female; Humans; Male; Pneumonia, Aspiration; Stroke | 2003 |
2 other study(ies) available for cabergoline and Stroke
| Article | Year |
|---|---|
Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.
Topics: Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Mirtazapine; Pituitary Neoplasms; Prolactin; Prolactinoma; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Stroke; Treatment Outcome; Tumor Burden | 2019 |
Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma.
Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Ergolines; Humans; Hypopituitarism; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Prolactin; Prolactinoma; Stroke | 2004 |